Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9YNP

Cryo-EM structure of Escherichia coli transcription initiation complex with GpA and pseudouridimycin (PUM)

Summary for 9YNP
Entry DOI10.2210/pdb9ynp/pdb
EMDB information73220
DescriptorDNA-directed RNA polymerase subunit alpha, MAGNESIUM ION, (1S)-1,4-anhydro-5-[(N-carbamimidoylglycyl-N~2~-hydroxy-L-glutaminyl)amino]-5-deoxy-1-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-D-ribitol, ... (11 entities in total)
Functional Keywordstranscription initiation complex, pseudouridimycin (pum), inhibitor, antibacterial agent, transcription, transferase-dna-rna-inhibitor complex, transferase/dna/rna/inhibitor
Biological sourceEscherichia coli str. K-12 substr. MG1655
More
Total number of polymer chains9
Total formula weight476063.42
Authors
You, L.L.,Ebright, R.H. (deposition date: 2025-10-11, release date: 2026-04-08)
Primary citationAnwar, A.F.,You, L.,Degen, D.,Burns, K.J.,Garza, M.J.,Ebright, R.H.,Del Valle, J.R.
Solid-phase synthesis and biological evaluation of des-hydroxy pseudouridimycin analogs.
Acs Med.Chem.Lett., 2026
Cited by
PubMed Abstract: Pseudouridimycin (PUM) is a C-nucleoside/peptide antibiotic that selectively inhibits bacterial RNA polymerase (RNAP) and exhibits potent activity against drug-resistant pathogens. However, PUM suffers from chemical instability due to self-immolative cleavage of its central hydroxamate bond. Here, we employed cryo-electron microscopy to determine structures of PUM () and a chemically stabilized des-hydroxy analog of PUM () bound to an RNAP transcription complex. Guided by the observed bound conformation, we developed an efficient solid-phase synthesis of 50 des-hydroxy PUM analogs modified at the Gln residue and Gdn-Gly tail. Several analogs retained low-micromolar RNAP-inhibitory activity, with a -substituted phenyl amidine analog () emerging as the most potent inhibitor (IC = 0.95 μM). These results establish a versatile synthetic platform and structural framework for optimizing stabilized PUM derivatives and provide a foundation for the development of RNAP-targeted therapeutics against resistant bacterial pathogens.
PubMed: 41890570
DOI: 10.1021/acsmedchemlett.5c00684
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (3.06 Å)
Structure validation

251801

건을2026-04-08부터공개중

PDB statisticsPDBj update infoContact PDBjnumon